4,807
Views
105
CrossRef citations to date
0
Altmetric
Review

Downstream processing of cell culture-derived virus particles

&
Pages 1451-1475 | Published online: 09 Jan 2014

References

  • Howarth JL, Lee YB, Uney JB. Using viral vectors as gene transfer tools (Cell Biology and Toxicology Special Issue: ETCS-UK 1 day meeting on genetic manipulation of cells). Cell Biol. Toxicol.26(1), 1–20 (2010).
  • Barrett PN, Portsmouth D, Ehrlich HJ. Developing cell culture-derived pandemic vaccines. Curr. Opin. Mol. Ther.12(1), 21–30 (2010).
  • Lauring AS, Jones JO, Andino R. Rationalizing the development of live attenuated virus vaccines. Nat. Biotechnol.28(6), 573–579 (2010).
  • Dudek T, Knipe DM. Replication-defective viruses as vaccines and vaccine vectors. Virology344(1), 230–239 (2006).
  • Ausubel LJ, Meseck M, Derecho I et al. cGMP production of an oncolytic rVSV vector for cancer treatment. Hum. Gene Ther.22, 489–497 (2011).
  • Pelkmans L. Viruses as probes for systems analysis of cellular signalling, cytoskeleton reorganization and endocytosis. Curr. Opin. Microbiol.8(3), 331–337 (2005).
  • Purkayastha A, Dasgupta I. Virus-induced gene silencing: a versatile tool for discovery of gene functions in plants. Plant Physiol. Biochem.47(11–12), 967–976 (2009).
  • Gould B, Kramer E. Virus-induced gene silencing as a tool for functional analyses in the emerging model plant Aquilegia (columbine, Ranunculaceae). Plant Methods3(1), 6 (2007).
  • Schnell MJ, McGettigan JP, Wirblich C, Papaneri A. The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Micro.8(1), 51–61 (2010).
  • Masetti A, De Luigi V, Burgio G. Effects of nucleopolyhedrovirus based product on Spodoptera littoralis. Bull. Insectol.61(2), 299–302 (2008).
  • Berling M, Blachere-Lopez C, Soubabere O et al.Cydia pomonella granulovirus genotypes overcome virus resistance in the codling moth and improve virus efficiency by selection against resistant hosts. Appl. Environ. Microbiol.75(4), 925–930 (2009).
  • Pandey A, Singh N, Sambhara S, Mittal SK. Egg-independent vaccine strategies for highly pathogenic H5N1 influenza viruses. Human Vaccines6(2), 178–188 (2010).
  • Genzel Y, Reichl U. Continuous cell lines as a production system for influenza vaccines. Expert Rev. Vaccines8(12), 1681–1692 (2009).
  • Mulligan RC. The basic science of gene therapy. Science260(5110), 926–932 (1993).
  • Collins SA, Guinn BA, Harrison PT, Scallan MF, O’Sullivan GC, Tangney M. Viral vectors in cancer immunotherapy: which vector for which strategy? Curr. Gene Ther.8(2), 66–78 (2008).
  • Alton E. Progress and prospects: gene therapy clinical trials (part 1). Gene Ther.14(20), 1439–1447 (2007).
  • Griesenbach U. Progress and prospects: gene therapy clinical trials (part 2). Gene Ther.14(22), 1555–1563 (2007).
  • Wright JF. Transient transfection methods for clinical adeno-associated viral vector production. Hum. Gene Ther.20(7), 698–706 (2009).
  • Ayuso E, Mingozzi F, Montane J et al. High AAV vector purity results in serotype- and tissue-independent enhancement of transduction efficiency. Gene Ther.17(4), 503–510 (2010).
  • Qu G, Bahr-Davidson J, Prado J et al. Separation of adeno-associated virus type 2 empty particles from genome containing vectors by anion-exchange column chromatography. J. Virol. Methods140(1–2), 183–192 (2007).
  • McDonald P, Victa C, Carter-Franklin JN, Fahrner R. Selective antibody precipitation using polyelectrolytes: a novel approach to the purification of monoclonal antibodies. Biotechnol. Bioeng.102(4), 1141–1151 (2009).
  • Tscheliessnig A, Ong D, Lee J et al. Engineering of a two-step purification strategy for a panel of monoclonal immunoglobulin M directed against undifferentiated human embryonic stem cells. J. Chromatogr. A1216(45), 7851–7864 (2009).
  • Kim HJ, Kim SY, Lim SJ, Kim JY, Lee SJ. One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae. Protein Expr. Purif.70(1), 68–74 (2010).
  • Ali A, Roossinck MJ. Rapid and efficient purification of Cowpea chlorotic mottle virus by sucrose cushion ultracentrifugation. J. Virol. Methods141(1), 84–86 (2007).
  • Loa CC, Lin TL, Wu CC et al. Purification of turkey coronavirus by Sephacryl size-exclusion chromatography. J. Virol. Methods104(2), 187–194 (2002).
  • Ro HS, Lee NJ, Lee CW, Lee HS. Isolation of a novel mycovirus OMIV in Pleurotus ostreatus and its detection using a triple antibody sandwich-ELISA. J. Virol. Methods,138(1–2), 24–29 (2006).
  • Fontes LVQ, Campos GS, Beck PA, Brandao CFL, Sardi SI. Precipitation of bovine rotavirus by polyethylen glycol (PEG) and its application to produce polyclonal and monoclonal antibodies. J. Virol. Methods123(2), 147–153 (2005).
  • Kröber T, Knochlein A, Eisold K, Kalbfuss-Zimmermann B, Reichl U. DNA depletion by precipitation in the purification of cell culture-derived influenza vaccines. Chem. Eng. Technol.33(6), 941–959 (2010).
  • Kerr IM, Martin EM. Simple method for isolation of encephalomyocarditis virus ribonucleic-acid J. Virol.9(3), 559–561 (1972).
  • Amosenko FA, Svitkin YV, Popova VD et al. Use of protamine sulphate for elimination of substrate DNA in poliovaccines produced on continuous cell lines. Vaccine9(3), 207–209 (1991).
  • Elbert LB, Terletskaya EN, Timofeev AV et al. Inactivated vaccine against tick-borne encephalitis (TBE) derived from heteroploid continuous monkey cell-line Vaccine7(5), 477–477 (1989).
  • Hammar L, Gilljam G. Extraction of HIV-1 in aqueous 2-phase systems to obtain a high-yield of gp120 AIDS Res. Hum. Retroviruses6(12), 1379–1388 (1990).
  • Morenweiser R. Downstream processing of viral vectors and vaccines. Gene Ther.12, S103–S110 (2005).
  • Braas GMF, Walker SG, Lyddiatt A. Recovery in aqueous two-phase systems of nanoparticulates applied as surrogate mimics for viral gene therapy vectors. J. Chromatogr. B Biomed. Sci. Appl.743(1–2), 409–419 (2000).
  • Hammar L, Merza M, Malm K, Eriksson S, Morein B. The use of aqueous 2-phase systems to concentrate and purify bovine leukemia-virus outer envelope protein gp51 Biotechnol. Appl. Biochem.11(3), 296–306 (1989).
  • Hammar L, Eriksson S, Malm K, Morein B. Concentration and purification of feline leukemia-virus (FELV) and its outer envelope protein gp70 by aqueous 2 phase systems J. Virol. Methods24(1–2), 91–102 (1989).
  • Gilljam G, Siridewa K, Hammar L. Purification of simian immunodeficiency virus, SIVMAC251, and of its external envelope glycoprotein, gp148. J. Chromatogr. A675(1–2), 89–100 (1994).
  • Burova E, Loffe E. Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications. Gene Ther.12, S5–S17 (2005).
  • Yamada K, Morishita N, Katsuda T, Kubo S, Gotoh A, Yamaji H. Adenovirus vector production using low-multiplicity infection of 293 cells. Cytotechnology59(3), 153–160 (2009).
  • Guo J, Yan R, Xu GD, Li WY, Zheng CY. Construction of the Vero cell culture system that can produce infectious HCV particles. Mol. Biol. Rep.36(1), 111–120 (2009).
  • Tan JM, Lancaster M, Hyatt A, van Driel R, Wong F, Wamer S. Purification of a herpes-like virus from abalone (Haliotis spp.) with ganglioneuritis and detection by transmission electron microscopy. J. Virol. Methods149(2), 338–341 (2008).
  • Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther.7(11), 910–913 (2000).
  • Segura MM, Kamen AA, Garnier A. Overview of current scalable methods for purification of viral vectors. In: Viral Vectors for Gene Therapy (Volume 737). Merten O-W, Al-Rubeai M (Eds). Humana Press Inc., NJ, USA, 89–116 (2011).
  • Segura MdlM, Garnier A, Kamen A. Purification and characterization of retrovirus vector particles by rate zonal ultracentrifugation. J. Virol. Methods133(1), 82–91 (2006).
  • Villegas GA, Arguelles MH, Castello AA, Mas NJ, Glikmann G. A rapid method to produce high yields of purified rotavirus particles. J. Virol. Methods104(1), 9–19 (2002).
  • Manes NP, Estep RD, Mottaz HM et al. Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions. J. Proteome Res.7(3), 960–968 (2008).
  • Segura MD, Kamen A, Garnier A. Downstream processing of oncoretroviral and lentiviral gene therapy vectors. Biotechnol. Adv.24(3), 321–337 (2006).
  • Hoekstra J, Deinhardt F. Simian sarcoma and feline leukemia virus antigens: isolation of species- and interspecies-specific proteins. Intervirology2(4), 222–230 (1973).
  • Harewood KR, Chang P, Higdon C, Larson D. The endogenous reverse transcriptase activity of gibbon ape lymphoma virus: characterization of the DNA product. Biochim. Biophys. Acta407(1), 14–23 (1975).
  • Tsuda F, Takahashi T, Takahashi K, Miyakawa Y, Mayumi M. Determination of antibody to hepatitis B core antigen by means of immune adherence hemagglutination. J. Immunol.115(3), 834–838 (1975).
  • Iordan AG, Mazhul LA, Shcheglovitova ON, Ageeva ON. Comparative study of the biological properties if influenza virus preparations purified by methods of centrifugation and chromatography. Vopr. Virusol.2, 150–154 (1983).
  • Okuda K, Ito K, Miyake K, Morita M, Ogonuki M. Purification of Japanese encephalitis virus vaccine by zonal centrifugation. J. Clin. Microbiol.1(1), 96–101 (1975).
  • Oroszlan S, Summers MR, Foreman C, Gilden RV. Murine type-c virus group-specific antigens – interstrain immunochemical, biophysical, and amino-acid sequence differences J. Virol.14(6), 1559–1574 (1974).
  • Drohan W, Kettmann R, Colcher D, Schlom J. Isolation of the mouse mammary tumor virus sequences not transmitted as germinal provirus in the C3H and RIII mouse strains. J. Virol.21(3), 986–995 (1977).
  • Burnette WN, Riggin CH, Mitchell WM. Physical and chemical properties of an oncornavirus associated with a murine adrenal carcinoma cell line. J. Virol.14(1), 110–115 (1974).
  • Hilfenhaus J, Köhler R, Gruschkau H. Large-scale purification of animal viruses in the RK-model zonal ultracentrifuge: III. Semliki Forest virus and vaccinia virus. J. Biol. Stand.4(4), 285–293 (1976).
  • Chattopadhyay SK, Hartley JW, Lander MR, Kramer BS, Rowe WP. Biochemical characterization of the amphotropic group of murine leukemia viruses. J. Virol.26(1), 29–39 (1978).
  • Heinz FX, Kunz C, Fauma H. Preparation of a highly purified vaccine against tick-borne encephalitis by continuous flow zonal ultracentrifugation. J. Med. Virol.6(3), 213–221 (1980).
  • Kumar AAP, Mani KR, Palaniappan C, Bhau LNR, Swaminathan K. Purification, potency and immunogenicity analysis of Vero cell culture-derived rabies vaccine: a comparative study of single-step column chromatography and zonal centrifuge purification. Microb. Infect.7(9–10), 1110–1116 (2005).
  • Smith GL, Moss B. Infectious poxvirus vectors have capacity for at least 25000 base pairs of foreign DNA. Gene25(1), 21–28 (1983).
  • Shibley GP, Manousos M, Munch K et al. New method for large-scale growth; and concentration of the Epstein–Barr viruses. Appl. Environ. Microbiol.40(6), 1044–1048 (1980).
  • Wheeler CM, Robertson BH, Van Nest G, Dina D, Bradley DW, Fields HA. Structure of the hepatitis A virion: peptide mapping of the capsid region. J. Virol.58(2), 307–313 (1986).
  • Gilden RV, Oroszlan S, Huebner RJ. Antigenic differentiation of M-MSV(O) from mouse, hamster, and cat C-type viruses. Virology43(3), 722–724 (1971).
  • Rodrigues T, Carrondo MJT, Alves PM, Cruz PE. Purification of retroviral vectors for clinical application: biological implications and technological challenges. J. Biotechnol.127(3), 520–541 (2007).
  • Reeves L, Cornetta K. Clinical retroviral vector production: step filtration using clinically approved filters improves titers. Gene Ther.7(23), 1993–1998 (2000).
  • Segura MD, Kamen A, Trudel P, Garnier A. A novel purification strategy for retrovirus gene therapy vectors using heparin affinity chromatography. Biotechnol. Bioeng.90(4), 391–404 (2005).
  • Kalbfuss B, Genzel Y, Wolff M, Zimmermann A, Morenweiser R, Reichl U. Harvesting and concentration of human influenza A virus produced in serum-free mammalian cell culture for the production of vaccines. Biotechnol. Bioeng.97(1), 73–85 (2007).
  • Birch JR, Racher AJ. Antibody production. Adv. Drug Del. Rev.58(5–6), 671–685 (2006).
  • Kern G, Krishnan M. Virus removal by filtration: points to consider. BioPharm Int.19(10), 32 (2006).
  • Roberts PL, Feldman P, Crombie D, Walker C, Lowery K. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions. Biologicals38(2), 303–310 (2010).
  • van Reis R, Brake JM, Charkoudian J, Burns DB, Zydney AL. High-performance tangential flow filtration using charged membranes. J. Membr. Sci.159(1–2), 133–142 (1999).
  • Grzenia DL, Carlson JO, Wickramasinghe SR. Tangential flow filtration for virus purification. J. Membr. Sci.321(2), 373–380 (2008).
  • Pujar NS, Zydney AL. Electrostatic and electrokinetic interactions during protein-transport through narrow pore membranes Ind. Eng. Chem. Res.33(10), 2473–2482 (1994).
  • Saksena S, Zydney AL. Effect of solution pH and ionic-strength on the separation of albumin from immunoglobulins (IgG) by selective filtration Biotechnol. Bioeng.43(10), 960–968 (1994).
  • van Eijndhoven R, Saksena S, Zydney AL. Protein fractionation using electrostatic interactions in membrane filtration Biotechnol. Bioeng.48(4), 406–414 (1995).
  • van Reis R, Zydney A. Bioprocess membrane technology. J. Membr. Sci.297(1–2), 16–50 (2007).
  • van Reis R, Gadam S, Frautschy LN et al. High performance tangential flow filtration. Biotechnol. Bioeng.56(1), 71–82 (1997).
  • Grzenia DL, Wickramasinghe SR, Carlson JO. Ultrafiltration of Parvovirus. Sep. Sci. Technol.42(11), 2387–2403 (2007).
  • Jungbauer A, Hahn R. Polymethacrylate monoliths for preparative and industrial separation of biomolecular assemblies. J. Chromatogr. A1184(1–2), 62–79 (2008).
  • Jungbauer A. Chromatographic media for bioseparation. J. Chromatogr. A1065(1), 3–12 (2005).
  • Gagnon P. Hydroxyapatite for biomolecule purification. Genetic Engineering & Biotechnology News30(7), 28–29 (2010).
  • Konz JO, Lee AL, Lewis JA, Sagar SL. Development of a purification process for adenovirus: controlling virus aggregation to improve the clearance of host cell DNA. Biotechnol. Prog.21(2), 466–472 (2005).
  • Rodrigues T, Carvalho A, Roldao A, Carrondo MJT, Alves PM, Cruz PE. Screening anion-exchange chromatographic matrices for isolation of onco-retroviral vectors. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.837(1–2), 59–68 (2006).
  • Chen Z, Hsu F-C, Battigelli D, Chang H-C. Capture and release of viruses using amino-functionalized silica particles. Anal. Chim. Acta569(1–2), 76–82 (2006).
  • Heyward JT, Klimas RA, Stapp MD, Obijeski JF. The rapid concentration and purification of influenza virus from allantoic fluid. Arch. Virol.55(1–2), 107–119 (1977).
  • Schnabel R, Langer P. Controlled-pore glass as a stationary phase in chromatography. J. Chromatogr. A544, 137–146 (1991).
  • Ljunglof A, Bergvall P, Bhikhabhai R, Hjorth R. Direct visualisation of plasmid DNA in individual chromatography adsorbent particles by confocal scanning laser microscopy. J. Chromatogr. A844(1–2), 129–135 (1999).
  • Ferreira GNM. Chromatographic approaches in the purification of plasmid DNA for therapy and vaccination. Chem. Eng. Technol.28(11), 1285–1294 (2005).
  • Podgornik A, Vidic J, Jancar J, Lendero N, Frankovic V, Strancar A. Noninvasive methods for characterization of large-volume monolithic chromatographic columns. Chem. Eng. Technol.28(11), 1435–1441 (2005).
  • Hahn R, Tscheliessnig A, Bauerhansl P, Jungbauer A. Dispersion effects in preparative polymethacrylate monoliths operated in radial-flow columns. J. Biochem. Biophys. Methods70(1), 87–94 (2007).
  • Podgornik A, Jancar J, Mihelic I, Barut M, Strancar A. Large volume monolithic stationary phases: preparation, properties, and applications. Acta Chimica Slovenica57(1), 1–8 (2010).
  • Plieva FM, Seta ED, Galaev IY, Mattiasson B. Macroporous elastic polyacrylamide monolith columns: processing under compression and scale-up. Sep. Purif. Technol.65(1), 110–116 (2009).
  • Trilisky EI, Lenhoff AM. Flow-dependent entrapment of large bioparticles in porous process media. Biotechnol. Bioeng.104(1), 127–133 (2009).
  • Jungbauer A, Hahn R. Monoliths for fast bioseparation and bioconversion and their applications in biotechnology. J. Sep. Sci.27(10–11), 767–778 (2004).
  • Charcosset C. Review: purification of proteins by membrane chromatography. J. Chem. Technol. Biotechnol.71(2), 95–110 (1998).
  • Charcosset C. Membrane processes in biotechnology: an overview. Biotechnol. Adv.24(5), 482–492 (2006).
  • Ghosh R. Protein separation using membrane chromatography: opportunities and challenges. J. Chromatogr. A952(1–2), 13–27 (2002).
  • Vicente T, Fáber R, Alves PM, Carrondo MJT, Mota JPB. Impact of ligand density on the optimization of ion-exchange membrane chromatography for viral vector purification. Biotechnol. Bioeng.108(6), 1347–1359 (2011).
  • Gagnon P. The emerging generation of chromatography tools for virus purification. BioProcess Int.6(Suppl. 6), 24, 26, 28–30 (2008).
  • Wolff MW, Siewert C, Hansen SP, Faber R, Reichl U. Purification of cell culture-derived modified vaccinia ankara virus by pseudo-affinity membrane adsorbers and hydrophobic interaction chromatography. Biotechnol. Bioeng.107(2), 312–320 (2010).
  • Gagnon P. Monoliths emerge as key purification methodology. Genetic Engineering & Biotechnology News28(14), 1 (2008).
  • Kalbfuss B, Wolff M, Geisler L et al. Direct capture of influenza A virus from cell culture supernatant with Sartobind anion-exchange membrane adsorbers. J. Membr. Sci.299(1–2), 251–260 (2007).
  • Koerber JT, Jang JH, Yu JH, Kane RS, Schaffer DV. Engineering adeno-associated virus for one-step purification via immobilized metal affinity chromatography. Hum. Gene Ther.18(4), 367–378 (2007).
  • Opitz L, Hohlweg J, Reichl U, Wolff MW. Purification of cell culture-derived influenza virus A/Puerto Rico/8/34 by membrane-based immobilized metal affinity chromatography. J. Virol. Methods161(2), 312–316 (2009).
  • Opitz L, Lehmann S, Reichl U, Wolff MW. Sulfated membrane adsorbers for economic pseudo-affinity capture of influenza virus particles. Biotechnol. Bioeng.103(6), 1144–1154 (2009).
  • Segura MM, Kamen A, Lavoie MC, Garnier A. Exploiting heparin-binding properties of MoMLV-based retroviral vectors for affinity chromatography. J. Chromatogr. B846(1–2), 124–131 (2007).
  • Hu JZ, Ni YY, Dryman BA, Meng XJ, Zhang CM. Purification of porcine reproductive and respiratory syndrome virus from cell culture using ultrafiltration and heparin affinity chromatography. J. Chromatogr. A1217(21), 3489–3493 (2010).
  • Cameron-Smith R, Harbour C. Removal of poliovirus type 1 from a protein mixture using an immunoaffinity chromatography column. Biomed. Chromatogr.15(7), 471–483 (2001).
  • Williams SL, Eccleston ME, Slater NKH. Affinity capture of a biotinylated retrovirus on macroporous monolithic adsorbents: towards a rapid single-step purification process. Biotechnol. Bioeng.89(7), 783–787 (2005).
  • Chen GY, Chen CY, Chang MDT, Matsuura Y, Hu YC. Concanavalin A affinity chromatography for efficient baculovirus purification. Biotechnol. Prog.25(6), 1669–1677 (2009).
  • Opitz L, Salaklang J, Buttner H, Reichl U, Wolff MW. Lectin-affinity chromatography for downstream processing of MDCK cell culture derived human influenza A viruses. Vaccine25(5), 939–947 (2007).
  • Nitsche A, Kurth A, Dunkhorst A et al. One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX. BMC Biotechnol.7, 48 (2007).
  • Gagnon P. Chromatographic purification of virus particles. In: Encyclopedia of Industrial Biotechnology (Volume 3). Flickinger MC (Ed.). John Wiley & Sons, Inc., NY, USA, 1591–1611 (2010).
  • Ye KM, Jin S, Ataai MM, Schultz JS, Ibeh J. Tagging retrovirus vectors with a metal binding peptide and one-step purification by immobilized metal affinity chromatography. J. Virol.78(18), 9820–9827 (2004).
  • Patel DC, Luo RG. Protein adsorption dissociation constants in various types of biochromatography. In: Adsorption and its Application in Industry and Environmental Protection (Volume 1: Applications in Industry). Dabrowski A (Ed.). Elsevier, Amsterdam, The Netherlands (1999).
  • Andreadis ST, Roth CM, Le Doux JM, Morgan JR, Yarmush ML. Large-scale processing of recombinant retroviruses for gene therapy. Biotechnol. Prog.15(1), 1–11 (1999).
  • Wolff MW, Siewert C, Lehmann S et al. Capturing of cell culture-derived modified Vaccinia Ankara virus by ion exchange and pseudo-affinity membrane adsorbers. Biotechnol. Bioeng.105(4), 761–769 (2010).
  • Opitz L, Zimmermann A, Lehmann S et al. Capture of cell culture-derived influenza virus by lectins: strain independent, but host cell dependent. J. Virol. Methods154(1–2), 61–68 (2008).
  • Graumann K, Ebenbichler AA. Development and scale up of preparative HIC for the purification of a recombinant therapeutic protein. Chem. Eng. Technol.28(11), 1398–1407 (2005).
  • Kramarczyk JF, Kelley BD, Coffman JL. High-throughput screening of chromatographic separations: II. Hydrophobic interaction. Biotechnol. Bioeng.100(4), 707–720 (2008).
  • Lu Y, Williamson B, Gillespie R. Recent advancement in application of hydrophobic interaction chromatography for aggregate removal in industrial purification process. Curr. Pharm. Biotechnol.10(4), 427–433 (2009).
  • Wang FH, Dai XJ, Gong BL. New method for preparation of hydrophobic interaction chromatographic stationary phases based on polymer-grafted silica and their chromatographic properties. J. Appl. Polym. Sci.118(3), 1513–1519 (2010).
  • O’Riordan CR, Lachapelle AL, Vincent KA, Wadsworth SC. Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). J. Gene Med.2(6), 444–454 (2000).
  • Kuiper M, Sanches RM, Walford JA, Slater NKH. Purification of a functional gene therapy vector derived from Moloney murine leukaemia virus using membrane filtration and ceramic hydroxyapatite chromatography. Biotechnol. Bioeng.80(4), 445–453 (2002).
  • Kessler LC, Gueorguieva L, Rinas U, Seidel-Morgenstern A. Step gradients in 3-zone simulated moving bed chromatography: application to the purification of antibodies and bone morphogenetic protein-2. J. Chromatogr. A1176(1–2), 69–78 (2007).
  • Juza M, Mazzotti M, Morbidelli M. Simulated moving-bed chromatography and its application to chirotechnology. Trends Biotechnol.18(3), 108–118 (2000).
  • Kessler LC, Seidel-Morgenstern A. Theoretical study of multicomponent continuous countercurrent chromatography based on connected 4-zone units. J. Chromatogr. A1126(1–2), 323–337 (2006).
  • Abel S, Babler MU, Arpagaus C, Mazzotti M, Stadler J. Two-fraction and three-fraction continuous simulated moving bed separation of nucleosides. J. Chromatogr. A1043(2), 201–210 (2004).
  • Paredes G, Abel S, Mazzotti M, Morbidelli M, Stadler J. Analysis of a simulated moving bed operation for three-fraction separations (3F-SMB). Ind. Eng. Chem. Res.43(19), 6157–6167 (2004).
  • Coffman JL, Kramarczyk JF, Kelley BD. High-throughput screening of chromatographic separations: I. Method development and column modeling. Biotechnol. Bioeng.100(4), 605–618 (2008).
  • Vicente T, Mota JPB, Peixoto C, Alves PM, Carrondo MJT. Modeling protein binding and elution over a chromatographic surface probed by surface plasmon resonance. J. Chromatogr. A1217(13), 2032–2041 (2010).
  • Vicente T, Peixoto C, Alves PM, Carrondo MJT. Modeling electrostatic interactions of baculovirus vectors for ion-exchange process development. J. Chromatogr. A1217(24), 3754–3764 (2010).
  • Petrides DP, Koulouris A, Lagonikos PT. The role of process simulation in pharmaceutical process development and product commercialization. Pharmaceutical Engineering22(1), 1–8 (2002).
  • Neumann K, Schwindt C, Trautmann N. Advanced production scheduling for batch plants in process industries. Or Spectrum24(3), 251–279 (2002).
  • Brooks CA, Cramer SM. Steric mass-action ion exchange: displacement profiles and induced salt gradients. AICHE J.38(12), 1969–1978 (1992).
  • Vicente T, Sousa MFQ, Peixoto C, Mota JPB, Alves PM, Carrondo MJT. Anion-exchange membrane chromatography for purification of rotavirus-like particles. J. Membr. Sci.311(1–2), 270–283 (2008).
  • Gottschalk U. Disposables in downstream processing. In: Disposable Bioreactors (Volume 115). Eibl R, Eibl D (Eds). Springer-Verlag, Heidelberg, Germany, 171–183 (2009).
  • Nakamae T, Tanaka N, Nakanishi K et al. Chondroitinase ABC promotes corticospinal axon growth in organotypic cocultures. Spinal Cord47(2), 161–165 (2009).
  • World Health Organization. WHO Expert Commitee on Biological Standardization. World Health Organ. Tech. Rep. Ser.878(i–vi), 1–101 (1998).
  • Sheng-Fowler L, Lewis Jr AM, Peden K. Issues associated with residual cell-substrate DNA in viral vaccines. Biologicals37(3), 190–195 (2009).
  • Iznaga AB, Frontera MC, Uramis JR, Gonzalez JBT, Parra YC, Gonzalez YM. DNA removal from a purification process of recombinant hepatitis B surface antigen. Electron. J. Biotechnol.10(1), 37–47 (2007).
  • Knezevic I, Stacey G, Petricciani J. WHO Study Group on cell substrates for production of biologicals, Geneva, Switzerland, 11–12 June 2007. Biologicals36(3), 203–211 (2008).
  • Urabe M, Xin KQ, Obara Y et al. Removal of empty capsids from type 1 adeno-associated virus vector stocks by anion-exchange chromatography potentiates transgene expression. Mol. Ther.13(4), 823–828 (2006).
  • Vellekamp G, Porter FW, Sutjipto S et al. Empty capsids in column-purified recombinant adenovirus preparations. Hum. Gene Ther.12(15), 1923–1936 (2001).
  • Whitfield RJ, Battom SE, Barut M, Gilham DE, Ball PD. Rapid high-performance liquid chromatographic analysis of adenovirus type 5 particles with a prototype anion-exchange analytical monolith column. J. Chromatogr. A1216(13), 2725–2729 (2009).
  • Lusky M. Good manufacturing practice production of adenoviral vectors for clinical trials. Hum. Gene Ther.16(3), 281–291 (2005).
  • Peixoto C, Ferreira TB, Sousa MFQ, Carrondo MJT, Alves PM. Towards purification of adenoviral vectors based on membrane technology. Biotechnol. Prog.24(6), 1290–1296 (2008).
  • Altaras NE, Aunins JG, Evans RK, Kamen A, Konz JO, Wolf JJ. Production and formulation of adenovirus vectors. In: Gene Therapy and Gene Delivery Systems (Volume 99). Scheper T (Ed.). Springer-Verlag, Berlin, Germany, 193–260 (2005).
  • Eglon MN, Duffy AM, O’Brien T, Strappe PM. Purification of adenoviral vectors by combined anion exchange and gel filtration chromatography. J. Gene Med.11(11), 978–989 (2009).
  • Duffy AM, O’Doherty AM, O’Brien T, Strappe PM. Purification of adenovirus and adeno-associated virus: comparison of novel membrane-based technology to conventional techniques. Gene Ther.12, S62–S72 (2005).
  • Okada T, Nonaka-Sarukawa M, Uchibori R et al. Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes. Hum. Gene Ther.20(9), 1013–1021 (2009).
  • Rodrigues T, Carvalho A, Carmo M, Carrondo MJT, Alves PM, Cruz PE. Scateabte purification process for gene therapy retroviral vectors. J. Gene Med.9(4), 233–243 (2007).
  • Lesch HP, Laitinen A, Peixoto C et al. Production and purification of lentiviral vectors generated in 293T suspension cells with baculoviral vectors. Gene Ther.18(6), 531–538 (2011).
  • Working PK, Lin A, Borellini F. Meeting product development challenges in manufacturing clinical grade oncolytic adenoviruses. Oncogene24(52), 7792–7801 (2005).
  • Wolff MW, Reichl U. Downstream processing: from egg to cell culture-derived influenza virus particles. Chem. Eng. Technol.31(6), 846–857 (2008).
  • Kalashnikova I, Ivanova N, Tennikova T. Development of a strategy of influenza virus separation based on pseudoaffinity chromatography on short monolithic columns. Anal. Chem.80(6), 2188–2198 (2008).
  • Plotkin SA. Vaccination against the major infectious diseases. Comptes Rendus De L Academie Des Sciences Serie Iii-Sciences De La Vie-Life Sciences322(11), 943–951 (1999).
  • Marcum JA. From the molecular genetics revolution to gene therapy: translating basic research into medicine. J. Lab. Clin. Med.146(6), 312–316 (2005).
  • Le Doux JM, Morgan JR, Yarmush ML. Removal of proteoglycans increases efficiency of retroviral gene transfer. Biotechnol. Bioeng.58(1), 23–34 (1998).
  • Le Doux JM, Morgan JR, Snow RG, Yarmush ML. Proteoglycans secreted by packaging cell lines inhibit retrovirus infection. J. Virol.70(9), 6468–6473 (1996).
  • Slingsby JH, Baban D, Sutton J et al. Analysis of 4070A envelope levels in retroviral preparations and effect on target cell transduction efficiency. Hum. Gene Ther.11(10), 1439–1451 (2000).
  • Pedro L, Soares SS, Ferreira GNM. Purification of bionanoparticles. Chem. Eng. Technol.31(6), 815–825 (2008).
  • Grzenia DL, Carlson JO, Czermak P, Han BB, Specht RK, Wickramasinghe SR. Purification of densonucleosis virus by tangential flow ultrafiltration. Biotechnol. Prog.22(5), 1346–1353 (2006).
  • Pfeifer A, Verma IM. Gene therapy: promises and problems. Annu. Rev. Genomics Hum. Genet.2(1), 177–211 (2001).
  • Salo RJ, Mayor HD. Isoelectric-focusing of parvoviruses. Intervirology10(2), 87–93 (1978).
  • Harrap KA. The structure of nuclear polyhedrosis viruses: II. The virus particle. Virology50(1), 124–132 (1972).
  • Ayres MD, Howard SC, Kuzio J, Lopezferber M, Possee RD. The complete DNA-sequence of Autographa-Californica nuclear polyhedrosis-virus. Virology202(2), 586–605 (1994).
  • Yang Y, Lo S-L, Yang J et al. Polyethylenimine coating to produce serum-resistant baculoviral vectors for in vivo gene delivery. Biomaterials30(29), 5767–5774 (2009).
  • Bujarski JJ. Bromovirus Isolation and RNA Extraction In: Methods in Molecular Biology: Plant Virology Protocols: From Virus Isolation to Transgenic Resistance (Volume 81). Foster GD, Taylor SC (Eds). Humana Press Inc., NJ, USA, 183–188 (1998).
  • Condit R. Principles of Virology. In: Fields Virology (Volume 1). Knipe D, Howley P (Eds). Lippincott Williams & Wilkins, PA, USA, 21 (2001).
  • Westaway EG, Brinton MA, Gaidamovich SY et al.Flaviviridae. Intervirology24(4), 183–192 (1985).
  • Melnick JL. Properties and classification of hepatitis-A virus Vaccine10, S24–S26 (1992).
  • Nasser A, Battagelli D, Sobsey M. Isoelectric focusing of hepatitis A virus in sucrose gradients. Israel J. Med. Sci.28, 73 (1992).
  • Liang TJ. Hepatitis B: the virus and disease. Hepatology49(S5), S13–S21 (2009).
  • Purcell R. The hepatitis C virus: overview. Hepatology26(S3), 11S–14S (1997).
  • Chang JT, Schmid MF, Rixon FJ, Chiu W. Electron cryotomography reveals the portal in the herpesvirus capsid. J. Virol.81(4), 2065–2068 (2007).
  • Granter A, Wille M, Whitney H, Robertson G, Ojkic D, Lang A. The genome sequence of an H11N2 avian influenza virus from a thick-billed murre (Uria lomvia) shows marine-specific and regional patterns of relationships to other viruses. Virus Genes41(2), 224–230 (2010).
  • Dea S, Elazhary MA, Roy RS. Les virus influenza chez l’homme et les animaux. Une revue de la littérature. Can. Vet. J.21, 171–178 (1980).
  • Bruce EA, Digard P, Stuart AD. The Rab11 pathway is required for influenza A virus budding and filament formation. J. Virol.84(12), 5848–5859 (2010).
  • Zhilinskaya IN, El-Saed LH, Ivanova NA, Golubev DE, Sokolov NN. Isolation of A2-Singapore-57 influenza virus V and S antigens by isoelectric focusing. Acta Virol.16(5), 436–439 (1972).
  • Brydak L. Studies on the adaptation of influenza-virus replication at low temperature. 5. Isoelectric-focusing studies Acta Microbiol. Pol.42(1), 29–33 (1993).
  • Molodkina LM, Molodkin VM, Vostryukhina OA, Kolikov VM, Golikova EV, Chernoberezhskii YM. Study of the electrophoretic mobility of A1 (Leningrad) and A3 (Leningrad) influenza-viruses Colloid Journal of the USSR48(1), 66–70 (1986).
  • Miller G, Lauffer M, Stanley W. Electrophoretic studies on PR8 influenza virus. J. Exp. Med.80(6), 549–559 (1944).
  • Misra UK, Kalita J. Overview: Japanese encephalitis. Prog. Neurobiol.91(2), 108–120 (2010).
  • Kitano T, Suzuki K, Yamaguchi T. Morphological, chemical, and biological characterization of Japanese encephalitis virus virion and its hemagglutinin. J. Virol.14(3), 631–639 (1974).
  • Kafri T. Gene delivery by lentivirus vectors an overview. Methods Mol. Biol.246, 367–390 (2004).
  • Berghäll H, Sirén J, Sarkar D et al. The interferon-inducible RNA helicase, MDA-5, is involved in measles virus-induced expression of antiviral cytokines. Microb. Infect.8(8), 2138–2144 (2006).
  • Kim HS, Jung SH, Kim SH et al. High-throughput analysis of mumps virus and the virus-specific monoclonal antibody on the arrays of a cationic polyelectrolyte with a spectral SPR biosensor. Proteomics6(24), 6426–6432 (2006).
  • Corbin A, Darlix JL. Functions of the 5´ leader of murine leukemia virus genomic RNA in virion structure, viral replication and pathogenesis, and MLV-derived vectors. Biochimie78(7), 632–638 (1996).
  • Cobo F, Concha Á, Marta Ortiz M. Human papillomavirus (HPV) type distribution in females with abnormal cervical cytology. A correlation with histological study. Open Virol. J.3, 60–66 (2009).
  • Beard JW, Wyckoff RWG. The pH stability of the papilloma virus protein. J. Biol. Chem.123(2), 461–470 (1938).
  • Oshima KH, Evansstrickfaden TT, Highsmith AK, Ades EW. The removal of phages T1 and PP7, and poliovirus from fluids with hollow-fiber ultrafilters with molecular-weight cutoffs of 50000, 13000, and 6000. Can. J. Microbiol.41(4–5), 316–322 (1995).
  • La Colia P, Marcialis MA, Mereu GP, Loddo B. Behaviour of a guanidine-dependent strain of poliovirus 1 in sucrose density and pH gradients. Cell. Mol. Life Sci.28(9), 1115–1117 (1972).
  • Mandel B. Characterization of type 1 poliovirus by electrophoretic analysis. Virology44(3), 554–568 (1971).
  • Butler M, Medlen AR, Taylor GR. Electrofocusing of viruses and sensitivity to desinfection Water Sci. Technol.17(10), 201–210 (1985).
  • Floyd R, Sharp DG. Viral aggregation – effects of salts on aggregation of poliovirus and reovirus at low-pH Appl. Environ. Microbiol.35(6), 1084–1094 (1978).
  • Simani S, Gholami A, Farahtaj F, Yousefi-Behzadi M, Fayaz A. Epidemiological survay of different rabies virus strains in Iran. J. Sci. IR Iran12(4), 315–319 (2001).
  • Best J, Banatvala JE, Almeida J, Waterson AP. Morphological characteristics of rubella virus. Lancet290(7509), 237–239 (1967).
  • Tzeng W-P, Frey TK. Mapping the rubella virus subgenomic promoter. J. Virol.76(7), 3189–3201 (2002).
  • Lundstrom K. Biology and application of alphaviruses in gene therapy. Gene Ther.12, S92–S97 (2005).
  • Ehrengruber MU, Lundstrom K. Alphaviruses: semliki forest virus and sindbis virus vectors for gene transfer into neurons. In: Current Protocols in Neuroscience. Gerfen C, Holmes A, Sibley D, Skolnick P, Wray S (Eds). John Wiley & Sons, Inc., NY, USA (2001).
  • Antoine G, Scheiflinger F, Dorner F, Falkner FG. The complete genomic sequence of the modified vaccinia ankara strain: comparison with other orthopoxviruses. Virology244(2), 365–396 (1998).
  • Carrascosa JL, Chichon FJ, Pereiro E et al. Cryo-x-ray tomography of vaccinia virus membranes and inner compartments. J. Struct. Biol.168(2), 234–239 (2009).
  • Mouillot L, Netter R. Identification of orthopox virus by isoelectrofocusing in a granulated gel. Ann. Microbiol. (Paris)B128(3), 417–419 (1977).
  • Douglas HW, Williams BL, Rondle CJM. Micro-electrophoresis of pox viruses in molar sucrose. J. Gen. Virol.5(3), 391–396 (1969).
  • Douglas HW, Rondle CJM, Williams BL. Micro-electrophoresis of cowpox and Vaccinia viruses in molar sucrose. J. Gen. Microbiol.42(1), 107–113 (1966).
  • Taylor DH, Bosmann HB. Measurement of the electrokinetic properties of Vaccinia and Reovirus by laser-illuminated whole-particle micro-electrophoresis J. Virol. Methods2(5), 251–260 (1981).
  • Michen B, Graule T. Isoelectric points of viruses. J. Appl. Microbiol.109(2), 388–397 (2010).
  • Goerke AR, To BC, Lee AL, Sagar SL, Konz JO. Development of a novel adenovirus purification process utilizing selective precipitation of cellular DNA. Biotechnol. Bioeng.91(1), 12–21 (2005).
  • Ugai H, Yamasaki T, Hirose M et al. Purification of infectious adenovirus in two hours by ultracentrifugation and tangential flow filtration. Biochem. Biophys. Res. Commun.331(4), 1053–1060 (2005).
  • Subramanian S, Altaras GM, Chen J, Hughes BS, Zhou W, Altaras NE. Pilot-scale adenovirus seed production through concurrent virus release and concentration by hollow fiber filtration. Biotechnol. Prog.21(3), 851–859 (2005).
  • Michel JP, Gingery M, Lavelle L. Efficient purification of bromoviruses by ultrafiltration. J. Virol. Methods122(2), 195–198 (2004).
  • Guo YF, Cheng AC, Wang MS, Zhou Y. Purification of anatid herpesvirus 1 particles by tangential-flow ultrafiltration and sucrose gradient ultracentrifugation. J. Virol. Methods161(1), 1–6 (2009).
  • Gracia-Valenzuela MH, Coronado-Molina D, Hernandez-Lopez J, Gollas-Galvan T. A simple method for purifying the white spot syndrome virus using ultrafiltration. Aquacult. Res.40(6), 737–743 (2009).
  • Nayak DP, Lehmann S, Reichl U. Downstream processing of MDCK cell-derived equine influenza virus. J. Chromatogr. B823(2), 75–81 (2005).
  • Wickramasinghe SR, Kalbfuss B, Zimmermann A, Thom V, Reichl U. Tangential flow microfiltration and ultrafiltration for human influenza A virus concentration and purification. Biotechnol. Bioeng.92(2), 199–208 (2005).
  • Czermak P, Grzenia DL, Wolf A et al. Purification of the densonucleosis virus by tangential flow ultrafiltration and by ion exchange membranes. Desalination224(1–3), 23–27 (2008).
  • Hensgen MI, Czermak P, Carlson JO, Wickramasinghe SR. Purification of minute virus of mice using high performance tangential flow filtration. Desalination250(3), 1121–1124 (2010).
  • Paul RW, Morris D, Hess BW, Dunn J, Overell RW. Increased viral titer through concentration of viral harvests from retroviral packaging lines. Hum. Gene Ther.4(5), 609–615 (1993).
  • Kotani H, Newton PB, Zhang SY et al. Improved methods of retrovrral vector transduction and production for gene-therapy. Hum. Gene Ther.5(1), 19–28 (1994).
  • Makino M, Ishikawa G, Yamaguchi K et al. Concentration of live retrovirus with a regenerated cellulose hollow-fiber, BMM. Arch. Virol.139(1–2), 87–96 (1994).
  • Koldej R, Cmielewski P, Stocker A, Parsons DW, Anson DS. Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production. J. Gene Med.7(11), 1390–1399 (2005).
  • Kamen A, Henry O. Development and optimization of an adenovirus production process. J. Gene Med.6, S184–S192 (2004).
  • Peixoto C, Ferreira TB, Carrondo MJT, Cruz PE, Alves PM. Purification of adenoviral vectors using expanded bed chromatography. J. Virol. Methods132(1–2), 121–126 (2006).
  • Transfiguracion J, Jorio H, Meghrous J, Jacob D, Kamen A. High yield purification of functional baculovirus vectors by size exclusion chromatography. J. Virol. Methods142(1–2), 21–28 (2007).
  • Wu CX, Soh KY, Wang S. Ion-exchange membrane chromatography method for rapid and efficient purification of recombinant baculovirus and baculovirus gp64 protein. Hum. Gene Ther.18(7), 665–672 (2007).
  • Zahn A, Allain JP. Hepatitis C virus and hepatitis B virus bind to heparin: purification of largely IgG-free virions from infected plasma by heparin chromatography. J. Gen. Virol.86, 677–685 (2005).
  • Kalbfuss B, Wolff M, Morenweiser R, Reichl U. Purification of cell culture-derived human influenza A virus by size-exclusion and anion-exchange chromatography. Biotechnol. Bioeng.96(5), 932–944 (2007).
  • Opitz L, Lehmann S, Zimmermann A, Reichl U, Wolff MW. Impact of adsorbents selection on capture efficiency of cell culture derived human influenza viruses. J. Biotechnol.131(3), 309–317 (2007).
  • Han BB, Specht R, Wickramasinghe SR, Carlson JO. Binding Aedes aegypti densonucleosis virus to ion exchange membranes. J. Chromatogr. A1092(1), 114–124 (2005).
  • Specht R, Han BB, Wickramasinghe SR et al. Densonucleosis virus purification by ion exchange membranes. Biotechnol. Bioeng.88(4), 465–473 (2004).
  • Smith RH, Levy JR, Kotin RM. A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells. Mol. Ther.17(11), 1888–1896 (2009).
  • Smith RH, Ding CT, Kotin RM. Serum-free production and column purification of adeno-associated virus type 5. J. Virol. Methods114(2), 115–124 (2003).
  • Davidoff AM, Ng CYC, Sleep S et al. Purification of recombinant adeno-associated virus type 8 vectors by ion exchange chromatography generates clinical grade vector stock. J. Virol. Methods121(2), 209–215 (2004).
  • Slepushkin V, Chang N, Cohen R et al. Large-scale purification of a lentiviral vector by size exclusion chromatography or mustang q ion exchange capsule. BioProcess. J.2, 89–95 (2003).
  • Transfiguracion J, Jaalouk DE, Ghani K, Galipeau J, Kamen A. Size-exclusion chromatography purification of high-titer vesicular stomatitis virus G glycoprotein-pseudotyped retrovectors for cell and gene therapy applications. Hum. Gene Ther.14(12), 1139–1153 (2003).
  • Williams SL, Nesbeth D, Darling DC, Farzaneh F, Slater NKH. Affinity recovery of Moloney murine leukaemia virus. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.820(1), 111–119 (2005).
  • Chtioui M, Trabelsi K, Kallel H. Purification of rabies virus produced on vero cells using chromatography techniques. In: Purification of Rabies Virus Produced on Vero Cells Using Chromatography Techniques. Smith R (Ed.). Springer-Verlag, NY, USA (2007).

Patents

  • GlaxoSmithKline Biologicals SA. WO2010089339-A1 (2010).
  • Merck & Co., Inc. WO2003097797-A2 (2003).
  • Baxter Healthcare SA. WO2003049766-A2 (2003).
  • Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. WO2008125361- A1 (2008).
  • Bavarian Nordic. A/S US 20100119552-A1 (2010).
  • BIA-Separations D.O.O. and Greenhills Biotechnology GmbH. WO2008006780-A1 (2008).

Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.